PHARMANIAGA PYRAZINAMIDE TABLET 500MG

Country: Malaysia

Language: English

Source: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Buy It Now

Active ingredient:

PYRAZINAMIDE

Available from:

PHARMANIAGA MANUFACTURING BERHAD

INN (International Name):

PYRAZINAMIDE

Units in package:

100 Tablets; 500 Tablets

Manufactured by:

PHARMANIAGA MANUFACTURING BERHAD

Patient Information leaflet

                                PHARMANIAGA PYRAZINAMIDE TABLET
Pyrazinamide (500mg)
_________________________________________________________________________________________________________
1
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
WHAT IS IN THIS LEAFLET
1.
What
Pharmaniaga
Pyrazinamide
Tablet 500mg is used for
2.
How
Pharmaniaga
Pyrazinamide
Tablet 500mg works
3.
Before
you
use
Pharmaniaga
Pyrazinamide Tablet 500mg
4.
How
to
use
Pharmaniaga
Pyrazinamide Tablet 500mg
5.
While you are using it
6.
Side effects
7.
Storage
and
disposal
of
Pharmaniaga
Pyrazinamide
Tablet
500mg
8.
Product description
9.
Manufacturer
and
Product
Registration Holder
10.
Date of revision
WHAT
PHARMANIAGA
PYRAZINAMIDE
TABLET 500MG IS USED FOR
Pharmaniaga
Pyrazinamide
Tablet
is
used
in
combination
with
other
medicines
to
treat
tuberculosis
also
known
as
TB.
Tuberculosis
is
a
bacterial infection that mainly affects
the lungs but it can also occur in other
organs or parts of the body.
HOW
PHARMANIAGA
PYRAZINAMIDE
TABLET 500MG WORKS
Pharmaniaga
Pyrazinamide
Tablet
contains
the
active
ingredient
pyrazinamide
which
belongs
to
a
group
of
medicines
called
anti-
infectives.
Pharmaniaga
Pyrazinamide
Tablet
works
by
killing
the
bacteria
which
cause TB but it must be used together
with
other
TB
drugs
and
cannot be
used alone.
BEFORE
YOU
USE
PHARMANIAGA
PYRAZINAMIDE TABLET 500MG
-
_When you must not use it _
Do
not
take
Pharmaniaga
Pyrazinamide Tablet 500mg if:
•
You have an allergy to any medicine
containing pyrazinamide.
•
You have an allergy to any of the
ingredients listed at the end of this
leaflet.
•
You are breast-feeding.
•
You have liver/kidney disease.
•
You have too much uric acid in your
blood
(also
called
hyperuricaemia)
which may or may not cause gout or
gouty arthritis.
Do
not
give
Pharmaniaga
Pyrazinamide Tablet to a child. The
safety of this medicine has not been
established in children.
Do
not
take
this
medicine
after
the
expiry date printed on the apck or if
the packaging is torn or shows signs of
tampering.
If
it
has
expired
or
is
damaged, re
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                (L)178mm
(W)193mm
01
26.07.17
- Amend wording and add in Date of revision.
VERSION NO.
DATE
REASON FOR CHANGE
02
31.07.17
- Add in Route of administration.
03
12.01.18
- Add in wording and amend PRP no and Date of revision.
04
02.02.18
- Amend wording and add in Lactation.
05
21.02.18
- Amend wording from _LACTATION_ to _Lactation_.
06
28.03.18
- Amend wording.
ARTWORK LOG
07
18.03.2020
- Amend wording and add in Date of revision.
08
26.11.2020
- Amend wording.
09
27.11.2020
- Amend wording.
10
08.12.2020
- Amend wording.
11
22.11.2021
- Amend wording and Date of revision.
12
27.07.2022
- Amend wording and Date of revision.
VERSION NO.
DATE
REASON FOR CHANGE
13
02.08.2022
- Amend wording and Date of revision.
ARTWORK LOG
artwork prepared by: cynthia yap
email: graphic@focusprint.info (Graphic Dept)
customer
PHARMANIAGA MANUFACTURING BERHAD
description
PYRAZINAMIDE (PRP 0055.12 290722)FRONT
size
attn
(L)178 X (W)193MM
date
02.08.2022
FOCUSPRINT
SDN BHD
DATE:
t: 603-8766 6030 f: 603-8766 6033 (Factory)
website: www.focusprint.com
1
PLEASE CHOP & SIGN FOR APPROVAL
colours
process
colours:
BLACK
IMPORTANT !
PLEASE NOTE THAT THIS COLOUR PRINT IS FOR VISUAL PURPOSE ONLY. OUTPUT
COLOUR MIGHT DIFFER IN ACTUAL PRODUCTION.
material
60G SIMILI
(L)178mm
(W)193mm
01
26.07.17
- Amend wording and add in Date of revision.
VERSION NO.
DATE
REASON FOR CHANGE
02
31.07.17
- Add in Route of administration.
03
12.01.18
- Add in wording and amend PRP no and Date of revision.
04
02.02.18
- Amend wording and add in Lactation.
05
21.02.18
- Amend wording from _LACTATION_ to _Lactation_.
06
28.03.18
- Amend wording.
ARTWORK LOG
07
18.03.2020
- Amend wording and add in Date of revision.
08
26.11.2020
- Amend wording.
09
27.11.2020
- Amend wording.
10
08.12.2020
- Amend wording.
11
22.11.2021
- Amend wording and Date of revision.
12
27.07.2022
- Amend wording and Date of revision.
VERSION NO.
DATE
REASON FOR CHANGE
13
02.08.2022
- Amend wording and Date of revision.
ARTWORK LOG
artwork prepared by: cynthia yap
email: graphic@focusprint.info 
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Malay 19-07-2022

Search alerts related to this product